Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E DAVIS

Showing results (21-30 of 596) with videos related to

Pageof 60
Sort By:
The Australian Journal of Physiotherapy|July 16, 2014
Acupuncture and physiotherapyM E Davis
The Medical Journal of Australia|September 21, 2011
Safety of incretin-based therapies for type 2 diabetesTimothy M E Davis
Diabetes, Obesity & Metabolism|April 2, 2014
Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairmentT M E Davis
Papua and New Guinea Medical Journal|December 17, 2009
Treatment of uncomplicated malaria in Papua New Guinea: what should be done?Timothy M E Davis
Expert Review of Clinical Pharmacology|October 30, 2015
Pharmacokinetic studies of antimalarials: recent developmentsTimothy M E Davis
Metabolism: Clinical and Experimental|August 17, 2021
Diabetes and metabolic dysfunction-associated fatty liver diseaseTimothy M E Davis
Internal Medicine Journal|March 8, 2018
Author replyTimothy M E Davis
The Medical Journal of Australia|September 2, 2008
Contemporary management of type 2 diabetes: blood glucose-lowering therapies and glycaemic targetsTimothy M E Davis
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2008
Ethnic diversity in type 2 diabetesT M E Davis
The Medical Journal of Australia|May 6, 2014
Dipeptidyl peptidase-4 inhibitors and cardiovascular safetyTimothy M E Davis
Pageof 60

Showing results (21-30 of 596) with videos related to

Sort By:
Pageof 60
The Australian Journal of Physiotherapy|July 16, 2014
Acupuncture and physiotherapyM E Davis
The Medical Journal of Australia|September 21, 2011
Safety of incretin-based therapies for type 2 diabetesTimothy M E Davis
Diabetes, Obesity & Metabolism|April 2, 2014
Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairmentT M E Davis
Papua and New Guinea Medical Journal|December 17, 2009
Treatment of uncomplicated malaria in Papua New Guinea: what should be done?Timothy M E Davis
Expert Review of Clinical Pharmacology|October 30, 2015
Pharmacokinetic studies of antimalarials: recent developmentsTimothy M E Davis
Metabolism: Clinical and Experimental|August 17, 2021
Diabetes and metabolic dysfunction-associated fatty liver diseaseTimothy M E Davis
Internal Medicine Journal|March 8, 2018
Author replyTimothy M E Davis
The Medical Journal of Australia|September 2, 2008
Contemporary management of type 2 diabetes: blood glucose-lowering therapies and glycaemic targetsTimothy M E Davis
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2008
Ethnic diversity in type 2 diabetesT M E Davis
The Medical Journal of Australia|May 6, 2014
Dipeptidyl peptidase-4 inhibitors and cardiovascular safetyTimothy M E Davis
Pageof 60